Home › Funds › Millennium Management › RLAY
Millennium Management position in RLAY
RELAY THERAPEUTICS INC · Health Care
Latest position (Q2 2026)591.67K sh
Reported value held$11.07M
Portfolio Weight0.00%
First reportedQ3 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 27.76K | $875.00K | New |
| Q4 2021 | 21.03K | $646.00K | Reduce |
| Q1 2022 | 13.76K | $412.00K | Reduce |
| Q2 2022 | 185.56K | $3.11M | Add |
| Q3 2022 | 40.23K | $900.00K | Reduce |
| Q4 2022 | 629.34K | $9.40K | Add |
| Q1 2023 | 190.00K | $3.13K | Reduce |
| Q2 2023 | 1.57M | $19.77M | Add |
| Q3 2023 | 958.20K | $8.06M | Reduce |
| Q4 2023 | 186.97K | $2.06M | Reduce |
| Q1 2024 | 227.91K | $1.89M | Add |
| Q2 2024 | 1.15M | $7.49M | Add |
| Q3 2024 | 1.06M | $7.50M | Reduce |
| Q4 2024 | 2.57M | $10.58M | Add |
| Q1 2025 | 2.94M | $7.71M | Add |
| Q2 2025 | 1.87M | $6.47M | Reduce |
| Q3 2025 | 744.04K | $3.88M | Reduce |
| Q4 2025 | 896.91K | $7.59M | Add |
| Q1 2026 | 347.73K | $3.46M | Reduce |
| Q2 2026 | 591.67K | $11.07M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding RLAY
- Fidelity Management & Research (FMR) 20.11M sh · $376.26M · Q2 2026
- Casdin Capital 16.04M sh · $300.02M · Q2 2026
- BlackRock Inc 15.29M sh · $286.04M · Q2 2026
- Geode Capital Management 4.73M sh · $88.45M · Q2 2026
- Vanguard Group 9.69M sh · $81.99M · Q4 2025
- Morgan Stanley 3.85M sh · $72.05M · Q2 2026
- Goldman Sachs Group 3.41M sh · $63.78M · Q2 2026
- Bank of America Corp 2.70M sh · $50.43M · Q2 2026
- Arrowstreet Capital 2.24M sh · $41.89M · Q2 2026
- Northern Trust Corp 1.95M sh · $36.55M · Q2 2026
- Franklin Resources 1.86M sh · $34.74M · Q2 2026
- Charles Schwab Investment Management 1.50M sh · $28.08M · Q2 2026